Clough Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$16.6M |
| 2 |
Wayfair
W
|
+$12.5M |
| 3 |
JPMorgan Chase
JPM
|
+$11.6M |
| 4 |
Morgan Stanley
MS
|
+$11M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$9.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$31M |
| 2 |
T-Mobile US
TMUS
|
+$23.2M |
| 3 |
WisdomTree India Earnings Fund ETF
EPI
|
+$21.4M |
| 4 |
Elevance Health
ELV
|
+$19.1M |
| 5 |
Home Depot
HD
|
+$18.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.79% |
| 2 | Healthcare | 19.01% |
| 3 | Technology | 18.3% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Real Estate | 7.92% |
Similar funds
Clough Capital Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Clough Capital Partners held 146 positions worth $1.02B, down 11% from $1.14B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Clough Capital Partners withdrew a net $181M in Q2 2019, closing 40 positions and reducing 47 holdings. Its most notable exit was WisdomTree India Earnings Fund ETF, an estimated $21.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Clough Capital Partners opened a new position in Thermo Fisher Scientific worth $10.6M.
- Clough Capital Partners's largest Q2 2019 buy was Thermo Fisher Scientific: 36,190 shares worth $10.6M.
- Clough Capital Partners added most to Microsoft in Q2 2019, an estimated $16.6M increase.
- Clough Capital Partners's biggest Q2 2019 reduction was Amazon, cutting an estimated $31M.
- Clough Capital Partners fully exited WisdomTree India Earnings Fund ETF in Q2 2019, selling an estimated $21.4M.
- Clough Capital Partners's ten largest holdings make up 34% of its $1.02B portfolio in Q2 2019.
- Clough Capital Partners opened 19 new positions and closed 40 in Q2 2019.
- Clough Capital Partners's portfolio value fell 11% quarter-over-quarter to $1.02B.
Based on Clough Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.